CIK 0002019410 · Non-accelerated filer<br>Emerging growth company
Caris Life Sciences, Inc.
Sign in to watch- Ticker
- CAI
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- TX
- Entity type
- operating
- EIN
- 852077369
- Phone
- (866) 771-8946
- Business address
- 750 W JOHN CARPENTER FREEWAY, SUITE 800, IRVING, TX, 75039
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $27,204,813
- in 3 filings
Net −$27,204,813. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-15 | HALBERT JON Director | Purchase | +68,000 | $14.56 | $990K | 704,598 |
| 2026-05-11 | Vacirca Jeff L Director | Purchase | +31,050 | $16.15 | $501K | 49,671 |
| 2025-11-07 | Spetzler David Baxley President | Purchase | +400 | $23.85 | $10K | 460,777 |
| 2025-11-07 | Denton John Russel See Remarks | Purchase | +4,184 | $24.09 | $101K | 9,184 |
| 2025-06-20 | Denton John Russel See Remarks | Purchase | +7,500 | $21.00 | $158K | 123,591 |
| 2025-06-20 | Brille Brian J See Remarks | Purchase | +30,000 | $21.00 | $630K | 162,428 |
Page 1 of 1 · 6 trades